Egalet (STU:EGP) EV-to-OCF: 14.64 (As of Sep. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Egalet EV-to-OCF?

Egalet STU:EGP EV-to-OCF is 14.64 as of Sep. 21, 2026. The stock has 2 warning signs investors should review.

EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Egalet's Enterprise Value is €70.58 Mil. Egalet's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2020 was €4.82 Mil. Therefore, Egalet's EV-to-OCF for today is 14.64.

The historical rank and industry rank for Egalet's EV-to-OCF or its related term are showing as below:

STU:EGP's EV-to-OCF is not ranked *
in the Drug Manufacturers industry.
Industry Median: 10.21
* Ranked among companies with meaningful EV-to-OCF only.

EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2026-09-21), Egalet's stock price is €0.00. Egalet's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2020 was €-0.970. Therefore, Egalet's PE Ratio (TTM) for today is At Loss.

Egalet  (STU:EGP) EV-to-OCF Explanation

EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Egalet's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.00/-0.970
=At Loss

Egalet's share price for today is €0.00.
Egalet's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.970.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.

Egalet EV-to-OCF Related Terms

Egalet EV-to-OCF Historical Data

* Premium members only.

The historical data trend for Egalet's EV-to-OCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Egalet EV-to-OCF Chart

Egalet Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
EV-to-OCF
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 -0.82 0.00 0.00

Egalet Quarterly Data
Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20
EV-to-OCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Egalet EV-to-OCF Calculation

Egalet's EV-to-OCF for today is calculated as:

EV-to-OCF=Enterprise Value (Today)/Cash Flow from Operations (TTM)
=70.580/4.82
=14.64

Egalet's current Enterprise Value is €70.58 Mil.
Egalet's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was €4.82 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EV-to-OCF →
What does a EV-to-OCF of 14.64 mean?
Egalet (STU:EGP) has a EV-to-OCF of 14.64 as of Sep. 21, 2026.
Is Egalet's EV-to-OCF too high?
Egalet's current EV-to-OCF is 14.64. The Drug Manufacturers industry median EV-to-OCF is 10.21. Egalet's value of 14.64 is 43.4% above this industry median.
How does Egalet's EV-to-OCF compare to CPHI and TLGT?
Egalet's EV-to-OCF of 14.64 can be compared against companies in the Drug Manufacturers industry. The industry median EV-to-OCF is 10.21. Egalet's value of 14.64 is 43.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Drug Manufacturers company?
The median EV-to-OCF among Drug Manufacturers companies is 10.21, based on 1,006 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Egalet's current EV-to-OCF of 14.64 is 43.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median EV-to-OCF is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Egalet's current EV-to-OCF is 14.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Egalet stock overvalued right now?
Egalet (STU:EGP) has a current EV-to-OCF of 14.64. The current EV-to-OCF is 14.64 and 43.4% above the Drug Manufacturers industry median of 10.21. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Egalet (STU:EGP), the current EV-to-OCF is 14.64 as of Sep. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Egalet Business Description

Address 600 Lee Road, Suite 100, Wayne, PA, USA, 19087
Zyla Life Sciences is a U.S based company focused on marketing its portfolio of medicines for pain and inflammation. The products offered by the company include Sprix, Oxaydo, Vivlodex, Zorvolex, Tivorbex and Indocin Oral Suspension among others.